Cormorant Asset Management’s Dermira, Inc. DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-170,000
Closed -$4.95M 74
2017
Q2
$4.95M Hold
170,000
0.82% 34
2017
Q1
$5.8M Sell
170,000
-2,083
-1% -$67.2K 0.84% 38
2016
Q4
$5.22M Hold
172,083
0.7% 40
2016
Q3
$5.82M Hold
172,083
0.64% 48
2016
Q2
$5.03M Buy
172,083
+2,083
+1% +$57.5K 0.71% 44
2016
Q1
$3.52M Hold
170,000
0.53% 46
2015
Q4
$5.88M Hold
170,000
0.7% 44
2015
Q3
$3.97M Hold
170,000
0.63% 42
2015
Q2
$2.98M Hold
170,000
0.4% 51
2015
Q1
$2.61M Sell
170,000
-30,000
-15% -$504K 0.4% 53
2014
Q4
$3.62M Buy
+200,000
New +$3.34M 0.56% 43

Other funds holding DERM

Cormorant Asset Management's DERM Position: Q3 2017 in Review

Cormorant Asset Management sold out of Dermira, Inc. (DERM) in Q3 2017, closing a stake of 170,000 shares — an estimated $4.95M sold.

Cormorant Asset Management first reported a position in DERM in Q4 2014 and held it in 11 quarters. The position peaked at $5.88M in Q4 2015. 123 funds tracked by Wall St. Rank hold DERM as of Q3 2017.

  • Cormorant Asset Management reported no remaining Dermira, Inc. position as of Q3 2017 after selling out during the quarter.
  • Cormorant Asset Management sold 170,000 Dermira, Inc. shares in Q3 2017, an estimated $4.95M.
  • Cormorant Asset Management first reported a position in Dermira, Inc. in Q4 2014 and held it in 11 quarters.
  • Cormorant Asset Management's Dermira, Inc. position peaked at $5.88M in Q4 2015.
  • 123 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2017.

Based on Cormorant Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.